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METHODS 
 
This review will focus on practical aspects of the assessment and treatment of alcohol use disorders 
from the perspective of the non-specialist hospital doctor or general practitioner. It is structured 
around a series of clinical guidelines developed by the National Institute for Health and Care 
Excellence (NICE) [1-3]. Three separate expert groups considered public health, physical, and 
psychological and social issues around alcohol use. The guidance is summarised in the form of 
clinical pathways at http://pathways.nice.org.uk/pathways/alcohol-use-disorders 
 
 
Introduction 
Alcohol can impact on both the incidence and course of many health conditions, and nearly 6% of all 
global deaths in 2012 were estimated to be attributable to its consumption [4]. A quarter of the UK 
adult population drinks alcohol in a way that is potentially or actually harmful to their health [5]. 
Between 2002 and 2012 there was a doubling of the number of episodes where an alcohol-related 
disease, injury or condition was the primary reason for hospital admission or a secondary diagnosis 
[6] . Despite the large numbers drinking alcohol at higher risk levels, a relatively low number access 
treatment [2]. Possible causes for this include missed opportunities to identify problems, limited 
access to specialist services, and underdeveloped care pathways. International studies have 
demonstrated that more than 20% of patients presenting to primary care are higher risk or 
dependent drinkers [7], yet the issue of alcohol is inadequately addressed. 
 
How are Alcohol Use Disorders (AUDs) defined? 
As the level of alcohol consumption goes up, so the risk of physical, psychological and social 
problems increases. Alcohol-related harm is a public health problem, and strategies that reduce 
average consumption across the whole population by even a small amount produce considerable 
health benefits. Increasing the cost of alcohol has been consistently associated with reduction in 
alcohol-related harm [8], and a minimum cost for a unit of alcohol has been under consideration in 
the UK [9].  
Alcoholic drinks have different strengths, and so alcohol is not measured by number of drinks but by 
number of ‘units’. In the UK, one unit is 8 grams of alcohol (equivalent to 10 millilitres of pure 
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ethanol) but this value is defined differently elsewhere (see [10], page 10). Box 1 shows how to 
calculate the number of units. The terminology used to define alcohol use disorders is currently 
evolving, with slightly different terms used by different organisations [11 12]. However, there is 
general agreement that there is no such thing as a ‘safe level’ of drinking, and that the risk of harm 
increases with either frequency of consumption and/or amount consumed on a drinking occasion 
[10]. In order to plan effective intervention strategies, the categories defined in table 1 are most 
commonly used. Figure 1 shows their prevalence in England. 
 
[Insert Figure 1 here] 
 
The term ‘addiction’ is not used in current classificatory systems, partly because it has pejorative 
connotations. The latest version of the Diagnostic and Statistical Manual (DSM-5) has removed the 
category of dependence, instead describing a spectrum of alcohol use disorders of different severity 
[13]. However, that the concept of alcohol dependence is important to describe individuals where 
the ability to control the frequency and extent of consumption has been completely eroded, while 
recognising that dependence may exist at different levels of severity [14 15].  
 
How can we identify alcohol use disorders? Identification and Brief Advice (IBA) 
As shown in figure 1, the majority of people with risky patterns of drinking are not dependent. A few 
minutes spent systematically identifying drinkers at increased risk of harm and delivering advice 
about moderating alcohol consumption has been shown to be an effective strategy in various 
settings [16 17], and the process of Identification and Brief Advice (IBA) should be offered as a first 
step in treatment [2]. NICE recommends that NHS professionals should carry out alcohol screening 
as part of routine practice [2], and all doctors should feel comfortable and confident in raising the 
topic of alcohol consumption in a consultation. However, the low level of detection and treatment 
suggests that generalists are not sufficiently proactive in screening potentially at-risk groups, 
including those 
• with relevant physical conditions (e.g. hypertension and gastrointestinal/liver disorders); 
• with mental health problems (e.g. anxiety or depression); 
• who have been assaulted; 
• at risk of self-harm; 
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• who regularly experience accidents or minor trauma; 
• who regularly attend Genito-Urinary Medicine clinics or repeatedly seek emergency 
contraception. 
 
The 'Alcohol Use Disorders Identification Test' (AUDIT, table 2) consists of 10 questions about 
drinking frequency and intensity, experience of alcohol-related problems, and signs of possible 
dependence [18],and is the ‘gold standard’ screening questionnaire for detecting drinkers at 
increasing or higher risk [2]. Furthermore, as box 2 shows, the AUDIT score can guide the clinician as 
to the best intervention, including brief advice or a referral to specialist services. Scores should be 
revised downward when screening women, or people under 18 or over 65. Biochemical measures 
such as liver function tests are not normally used for screening, but may be helpful in assessing the 
severity and progress of an established alcohol-related problem, or as part of a secondary care 
assessment [19].  
A guiding style that aims to build motivation and avoid confrontation is recommended, and 
motivational interviewing has shown considerable promise in this area. Although a review is beyond 
the scope of this article, useful materials can be found at www.motivationalinterviewing.org. 
 
What treatments are available for alcohol dependence? 
IBA is an important public health approach due to the numbers of people involved. However, even 
after gold-standard brief interventions in primary care, nearly two-thirds of individuals will still be 
drinking at an increasing or higher risk level [17]. At the ‘dependent’ end of the drinking spectrum, 
change is even more difficult to achieve. People with a moderate to severe level of alcohol 
dependence may benefit from more intensive help from mutual aid groups such as Alcoholic 
Anonymous and/or specialist treatment services [2].  Abstinence is the preferred goal for many such 
individuals, particularly for those whose organs have already been damaged through alcohol use, or 
for those who have previously attempted to cut down their drinking without success. In considering 
the correct level of treatment intensity it is important to consider risks, capacity to consent to 
treatment, the experience and outcome of previous episodes of treatment, motivation for change, 
and other existing problems including harm to others.  
There are three interventions that may assist the generalist in altering the drinking trajectory: 
1. Medically Assisted Withdrawal 
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The alcohol withdrawal syndrome develops when consumption is abruptly stopped or substantially 
reduced, and symptoms and signs appear within 6-8 hours. These include anxiety, tremor, sweating, 
nausea, tachycardia, and hypertension, usually peaking over 10-30 hours and subsiding within 2-3 
days. Seizures may occur in the first 12-48 hours (but rarely after this), and delirium tremens is a 
serious condition that occurs 48-72 hours after cessation of drinking characterised by coarse tremor, 
agitation, fever, tachycardia, profound confusion, delusions, (characteristically frightening) auditory 
and visual hallucinations, and possibly hyperpyrexia, ketoacidosis and circulatory collapse.  
Minor degrees of alcohol withdrawal are common, and can be managed with information, 
reassurance, and adequate fluid intake. However, the alcohol withdrawal syndrome is potentially 
life-threatening, and systematic reviews recommend long-acting benzodiazepines (chlordiazepoxide 
or diazepam) as the drug of choice for managing it and preventing serious complications such as 
seizures or delirium tremens [1 20]. The aim is to titrate the initial dose to the level of withdrawal 
symptoms and then slowly reduce the dose over 7-10 days using a standard ‘fixed dose’ protocol 
(see Table 3). Rating scales such as the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-
Ar) can be used to measure the severity of the withdrawal symptoms and more accurately adjust the 
dose, but the use of such a ‘symptom-triggered’ regimen is only recommended if trained staff are 
available e.g. in an inpatient setting [3]. Prescribing in the community for alcohol dependent patients 
without adequate assessment and support is not recommended, as successful withdrawal is unlikely, 
and there are significant associated clinical risks. This is a common scenario facing GPs, and 
expeditious referral to specialist services for support from a specialist alcohol nurse during 
medicated withdrawal is advised.   
Doses of benzodiazepines should be reduced for children and young people, older people, and 
people with impaired liver synthetic function e.g. reduced albumin or increased prothrombin time 
(where a benzodiazepine requiring less liver metabolism may be preferred e.g. oxazepam). Clinicians 
should be aware of complications of nutritional deficiency such as the Wernicke-Korsakoff Syndrome 
and how to prevent them [3]. Most episodes of medically assisted alcohol withdrawal can take place 
at home, but inpatient treatment should be considered if the person drinks more than 30 units of 
alcohol/day, a history of epilepsy, withdrawal-related seizures or delirium tremens, or co-morbid 
physical or mental health conditions [1]. 
2. Mutual Aid Facilitation 
Treatment of alcohol withdrawal is not sufficient on its own, and should be viewed as the precursor 
to a longer-term treatment and rehabilitation process. Research consistently shows that people with 
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alcohol dependence who have stopped drinking are vulnerable to relapse, and may have unresolved 
problems that predispose them to this [21]. Mutual aid groups (such as Alcoholics Anonymous and 
SMART Recovery) are a source of ongoing support for people seeking recovery from alcohol 
dependence, and for partners, friends, children and other family members. Long-term cohort studies 
show that people who actively participate in mutual aid are more likely to sustain their recovery 
[22], and NICE recommends that treatment staff routinely provide information about mutual aid 
groups and facilitate access for those who want to attend [1]. 
Clinicians should be aware of the range of mutual aid groups available locally and how to access 
them. Level of clinician knowledge about AA groups has been positively correlated with levels of 
referral [23], and attending a meeting is an invaluable learning experience. RCT evidence suggests 
that proactive efforts to engage patients with mutual aid groups increase attendance, particularly 
introducing the patient to a group member in advance of a meeting [24]. A simple three stage 
process to guide this is available (see www.nta.nhs.uk/uploads/mutualaid-fama.pdf). 
3. Relapse Prevention Medication 
Interventions based on psychological or social processes of change are the mainstay of treatment for 
alcohol dependence (see [25] for a review). Although research suggests that such treatments lead to 
improved outcomes when compared to no treatment at all, the evidence favouring one type of 
psychological intervention over another is less clear. Other factors such as therapist characteristics 
and service variables are also important. There is wide variation in the uptake and implementation 
of psychological approaches in the UK [1 26], and most practice involves an eclectic approach that 
combines strategies from various psychological approaches that typically lasts 12 weeks. In the 
individual who has decided to become abstinent from alcohol, this treatment is enhanced by both 
mutual aid group attendance and the prescribing of relapse prevention medication. The following 
medications can all be prescribed in primary care, though they may all be initiated and monitored by 
a specialist. 
Acamprosate and the opioid-antagonist naltrexone are both effective in increasing the time to first 
drink and to relapse in people with alcohol dependence who have achieved abstinence [1]. 
Acamprosate may also be neuroprotective, and is believed to act by altering the balance between 
excitatory and inhibitory neurotransmission [20]. Naltrexone appears to reduce cravings by reducing 
the reinforcing effect of alcohol consumption. Both should only be used in combination with an 
individual psychological intervention, started as soon as possible after withdrawal, and may be 
prescribed for 6 months or more depending on perceived benefit. Systematic reviews suggest a 
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number needed to treat to prevent return to any drinking of between 12 and 20 [27]. Disulfiram 
(Antabuse) works by interfering with the metabolism of alcohol, causing an accumulation of 
acetaldehyde in the body and so throbbing headache, facial flushing, palpitations, dyspnoea, 
tachycardia, nausea and vomiting within ten minutes of alcohol consumption. Its use as a deterrent 
is most suited to people who have abstinence as a goal, and who have someone to supervise 
consumption each day. Treatment should be started at least 24 hours after the last alcoholic drink, 
and disulfiram should be used with caution in pregnancy, liver disease, severe mental illness, stroke, 
heart disease or hypertension. Patients need to know about the symptoms caused by the interaction 
between alcohol and disulfiram, and the rare and unpredictable onset of hepatotoxicity which is 
unrelated to dose. 
Nalmefene is an opioid antagonist that is indicated for the reduction of alcohol consumption in 
adults with alcohol dependence who have a high drinking risk level (more than 7.5 units/day in men 
and 5 units/day in women), but without physical withdrawal symptoms and who do not need 
immediate medically assisted withdrawal. It should be initiated only in patients who continue to 
have a high drinking risk level two weeks after initial assessment, and it should only be prescribed in 
conjunction with continuous psychosocial support focused on treatment adherence and reducing 
alcohol consumption. Such psychosocial support can be delivered in primary care, and this seems to 
be a cost-effective approach to addressing higher risk drinking [28_ENREF_28]. The recommended 
dose is one oral tablet on each day the person perceives a risk of drinking, ideally 1-2 hours before 
the anticipated time of drinking. 
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SUMMARY POINTS 
 
 Alcohol use disorders exist across a spectrum, and public health measures to reduce the 
drinking of the whole population have considerable health benefits 
 All front-line clinicians should be aware of the potential effects of alcohol consumption, and 
be able to screen for AUDs using AUDIT 
 Brief interventions are quick and easy to deliver and have a potentially large impact on 
reducing hazardous and harmful drinking 
 Benzodiazepines are the medication of choice for medically assisted alcohol withdrawal 
 Relapse to drinking is common in the first year after stopping drinking, but psychological 
treatments, mutual aid groups and relapse prevention medication increase the likelihood of 
remaining abstinent  
 
 
 
TIPS FOR NON-SPECIALISTS 
 
 Consider the far reaching effects of alcohol, not only to individual physical and mental 
health, but to family members and the community as a whole 
 Screening for alcohol problems in all healthcare settings, and particularly in high risk 
populations 
 Providing structured brief advice and feedback is an effective strategy in high risk drinkers 
 Adopt a positive, motivational approach to managing AUDs 
 Take a long-term, stepped care perspective, moving to more intensive interventions when a 
less intensive option hasn’t worked 
 Promote attendance at mutual aid groups such as Alcoholics Anonymous or SMART 
Recovery UK wherever possible 
 
 
 
QUESTIONS FOR FUTURE RESEARCH 
 
 What methods are effective for assessing and diagnosing the presence and severity of alcohol 
use disorders in children and young people? 
 What are the most effective strategies for facilitating the delivering of alcohol identification and 
brief advice in routine clinical practice? 
 Is an assertive community treatment model for moderate to severe alcohol dependence 
clinically and cost effective compared with standard care? 
 For people with alcohol dependence, which medication is most likely to improve adherence and 
thereby promote abstinence and prevent relapse? 
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ADDITIONAL EDUCATIONAL RESOURCES 
 
[All free access] 
 
Public Health England Alcohol Learning Resources 
www.alcohollearningcentre.org.uk/ 
 
Alcohol Identification and Brief Advice e-learning project 
www.alcohollearningcentre.org.uk/eLearning/IBA 
 
NICE Pathways 
www.Pathways.nice.org.uk/pathways/alcohol-use-disorders 
 
A comprehensive perspective on the global consumption of alcohol, patterns of drinking, health 
consequences and policy responses 
www.who.int/substance_abuse/publications/global_alcohol_report/en/ 
 
A practical guide from the National Institute of Alcohol and Alcoholism in the USA 
http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/guide.pdf 
 
A detailed review of the causes and consequences of alcohol use disorders is found in chapter 2 of 
the NICE Clinical Practice Guideline 115 (www.nice.org.uk/CG115). 
 
 
INFORMATION RESOURCES FOR PATIENTS 
 
An interactive web-based programme to help people drink less 
www.nhs.uk/Change4Life/Pages/drink-less-alcohol.aspx 
 
Mutual aid organisations providing free meetings and support throughout the UK 
www.alcoholics-anonymous.org.uk/ 
www.smartrecovery.org.uk/ 
 
Help to find an alcohol treatment service: 
www.alcoholconcern.org.uk/concerned-about-alcohol/alcohol-services 
 
Adfam, a charity aiming to improve support for families affected by drug and alcohol problems 
www.adfam.org.uk/ 
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Calculating units of alcohol 
  
A drink's alcohol content is usually expressed by the standard measure ‘Alcohol by Volume’ or ABV. 
This is a measure of the amount of pure alcohol as a percentage of the total volume of liquid in a 
drink, and is found on the labels of cans and bottles. For example, if a can of beer has a label reading 
"5% ABV" or "alcohol volume 5%", this means that 5% of the volume of that drink is pure alcohol. 
  
You can work out how many units there are in any drink by multiplying the total volume of a drink 
(in ml) by its ABV (which is measured as a percentage) and dividing the result by 1,000: 
 
Number of units = Strength (ABV) x Volume (ml) ÷ 1,000 
 
For example, to work out the number of units in a pint (568ml) of strong lager (ABV 5%): 
 
Number of units = 5 (%) x 568 (ml) ÷ 1,000 = 2.84 
 
This is worth doing, as the increasing strength of many alcoholic drinks and the larger glass sizes 
served in bars mean that people are often drinking more alcohol than they realise. 
 
Units calculators are available e.g. http://www.nhs.uk/Tools/Pages/Alcohol-unit-calculator.aspx 
 
 
BOX 1: Units of alcohol and how to calculate them 
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Category of Drinking Definition 
 
AUDIT 
score 
Low risk No amount of alcohol consumption can be called ‘safe’, but 
risks of harm are low if below levels  
7 or less 
Increasing risk 
(‘hazardous’) 
Regularly drinking more than 2-3 units a day (women) and more 
than 3-4 units a day (men) 
8-15 
Higher risk  
(‘harmful’) 
Regularly drinking more than 6 units per day (women) or more 
than 8 units per day (men) 
Or more than 35 units per week (women) and more than 50 
units per week (men) 
16-19 
Dependence 
(as defined by the 
International 
Classification of 
Disorders (ICD-10)  
[11].  
A definite diagnosis of dependence should be made only if 
three or more of the following have been present together at 
the same time during the previous year: 
(a) a strong desire or sense of compulsion to drink alcohol 
(b) difficulties in controlling drinking behaviour in terms of its 
onset, termination, or levels of consumption 
(c) a physiological withdrawal state when drinking has ceased or 
been reduced, as evidenced by: the characteristic alcohol 
withdrawal syndrome; or use of the same (or a closely related) 
substance with the intention of relieving or avoiding withdrawal 
symptoms e.g. benzodiazepines 
(d) evidence of tolerance, such that increased quantities of 
alcohol are required in order to achieve the effects originally 
produced by lesser amounts 
(e) progressive neglect of alternative pleasures or interests 
because of alcohol consumption, increased amount of time 
necessary to obtain or drink alcohol or to recover from its 
effects 
(f) persisting with drinking alcohol despite clear evidence of 
overtly harmful consequences, such as harm to the liver, 
depressive mood states, or impaired cognitive functioning 
 
It is an essential characteristic of the dependence syndrome 
that either alcohol consumption or a desire to drink alcohol is 
present; the subjective awareness of compulsion to drink 
alcohol is most commonly seen during attempts to stop or 
control substance use 
20 or 
more 
 
TABLE 1: A classification and definition of Alcohol Use Disorders 
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ALCOHOL USE DISORDERS IDENTIFICATION TEST (AUDIT) 
 
1. How often do you have a drink containing 
alcohol?  
(0) Never 
(1) Monthly or less 
(2) 2 to 4 times a month 
(3) 2 to 3 times a week 
(4) 4 or more times a week 
6. How often during the last year have you 
needed a first drink in the morning to get 
yourself going after a heavy drinking session? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
2. How many units of alcohol do you have on a 
typical day when you are drinking? 
(0) 1 or 2 
(1) 3 or 4 
(2) 5 or 6 
(3) 7, 8 or 9 
(4) 10 or more 
7. How often during the last year have you had a 
feeling of guilt or remorse after drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
3. How often do you have 6 or more units if 
female, or 8 or more units of male, on a single 
occasion in the last year? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
8. How often during the last year have you been 
unable to remember what happened the night 
before because you had been drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
4. How often during the last year have you found 
that you were not able to stop drinking once you 
had started? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
9. Have you or someone else been injured as a 
result of your drinking? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
5. How often during the last year have you failed 
to do what was normally expected from you 
because of drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
10. Has a relative or friend, doctor or another 
health worker been concerned about your 
drinking or suggested that you cut down? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
 
                                                                           TOTAL SCORE: 
 
 
TABLE 2: The Alcohol Use disorders Identification Test (AUDIT)  
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The rationale: A large body of international research evidence indicates that 1 in 8 people drinking 
at increasing risk or higher risk levels who receive structured brief advice will reduce their drinking to 
within lower risk levels [2]. Raising the issue of alcohol consumption with patients often meets with 
a number of different attitudes, including indifference, confusion about what is and isn’t healthy, 
and possibly defensiveness and irritability. The clinician should ensure that they are aware of the 
facts about alcohol consumption and health-related harms in order to accurately convey the risks of 
drinking to the patient. It is important to avoid stigmatising terms like ‘alcoholic’, emphasising the 
concept of increasing risk with increasing consumption, and suggesting trying to cut down to a lower 
risk level rather than stopping. However, the clinician should also be able to detect alcohol 
dependence and refer on for specialist help.  
 
Stage 1: Raise the issue 
The most time and resource-effective strategy in non-specialist settings is to target those at greatest 
risk i.e. people with relevant physical (e.g. hypertension, gastrointestinal or liver problems) or 
mental health (anxiety or depression) conditions, at risk of self-harm, or who regularly experience 
accidents or minor trauma. 
Ask the first three questions on the AUDIT questionnaire (table 2) and score the answers (known as 
AUDIT-C).  
Score of 5+: suggests a high likelihood that the person is drinking at an increasing risk level, and the 
full AUDIT questionnaire should be administered. 
 
Stage 2: Administer and score the 10-item AUDIT questionnaire 
7 or less: this should be fed back in a positive manner e.g. re-iterate the sensible drinking guidelines 
and point out that people who exceed these levels increase their chances of alcohol-related health 
problems like accidents, injuries, high blood pressure, liver disease, cancer, and heart disease, whilst 
congratulating them for adhering to guidance. 
8-19: this suggests that the patient’s drinking pattern is in the increasing risk or higher risk band, and 
the clinician should move to offering brief advice as described in stage 3. 
 
Stage 3: Deliver structured Brief Advice 
Use an open-ended ‘transitional’ statement such as ‘how important is it for you to change your 
drinking?’, possibly accompanied by a simple ‘readiness ruler’ i.e. asking the patient to rate how 
confident they feel in making changes between 1 and 10. This can be followed by asking what would 
have to happen to make the number go up. 
A structured episode of brief advice may only last 5-10 minutes, and is best guided by a Structured 
Advice Tool (such as the one available at 
http://www.alcohollearningcentre.org.uk/alcoholeLearning/learning/IBA/Module4_v2/pdf/structure
d_advice_tool.pdf) 
This makes use of the FRAMES structure for brief interventions (Feedback, Responsibility, Advice, 
Menu, Empathy, Self-efficacy). The leaflet provides material to use for three of these elements: 
 Feedback on the patient’s level of drinking when compared to others, the common effects 
of drinking, and the potential benefits of reduction 
 A menu of options to support the attainment of their preferred drinking goal 
 Advice on units and limits 
The clinician should aim to be firm enough to ensure that the patient realises that it is their 
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responsibility to make the change (restating the need to reduce risk and encouraging the patient to 
begin now), whilst also showing empathy (e.g. ‘it can be very difficult to make these changes if 
everyone around you is drinking heavily’) and aiming to boost their confidence and self-efficacy (‘You 
mentioned you were going to drink a non-alcoholic drink first when you get home in the evening. 
That sounds like an excellent start. Let’s see how you get on and arrange another time to talk to 
discuss how you get on’). 
It is a good idea to offer a follow-up appointment to assess progress. An ‘extended brief 
intervention’ places greater emphasis on exploring the pros and cons of change and formulating a 
specific action plan. This approach is often based on the principles of motivational interviewing [29], 
and again is best guided by a structured leaflet such as the one available at: 
http://www.alcohollearningcentre.org.uk/alcoholeLearning/learning/IBA/Module5_v2/extended_int
ervention_worksheet.pdf 
A patient should be referred for more specialist alcohol assessment and intervention if they ask for 
such help, are already exhibit significant alcohol-related harm, have an AUDIT score of more than 20, 
or exhibit the features of the dependence syndrome. 
 
A step-by-step teaching module and full range of materials is available at 
www.alcohollearningcentre.org.uk/eLearning/ 
 
 
BOX 2: Delivering alcohol Identification and Brief Advice (IBA) in Practice 
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Daily alcohol 
consumption 
15-25 units 30-49 units 50-60 units 
Severity of 
alcohol 
dependence 
Moderate 
SADQ score 15-25 
Severe 
SADQ score 30-40 
Very severe 
SADQ score 
40-60 
Day 1 (starting 
dose) 
15mg four 
times/day 
25mg four 
times/day 
30mg four 
times/day 
40mg four 
times/daya 
50mg four 
times/dayb 
Day 2 10mg four 
times/day 
20mg four 
times/day 
25mg four 
times/day 
35mg four 
times/daya 
45mg four 
times/dayb 
Day 3 10mg three 
times/day 
15mg four 
times/day 
20mg four 
times/day 
30mg four 
times/day 
40mg four 
times/daya 
Day 4 5mg three 
times/day 
10mg four 
times/day 
15mg four 
times/day 
25mg four 
times/day 
35mg four 
times/daya 
Day 5 5mg 
twice/day 
10mg three 
times/day 
10mg four 
times/day 
20mg four 
times/day 
30mg four 
times/day 
Day 6 5mg at night 5mg three 
times/day 
10mg three 
times/day 
15mg four 
times/day 
25mg four 
times/day 
Day 7  5mg 
twice/day 
5mg three 
times/day 
10mg four 
times/day 
20mg four 
times/day 
Day 8  5mg at night 5mg 
twice/day 
10mg three 
times/day 
15mg four 
times/day 
Day 9   5mg at night 5mg three 
times/day 
10mg four 
times/day 
Day 10    5mg 
twice/day 
10mg three 
times/day 
Day 11    5mg at night 5mg three 
times/day 
Day 12     5mg 
twice/day 
Day 13     5mg at night 
 
SADQ = Severity of Alcohol Dependence Questionnaire. A copy can be found at 
http://www.alcohollearningcentre.org.uk/Topics/Latest/Resource/?cid=4615 
 
a
 Doses of chlordiazepoxide in excess of 30mg four times/day should be prescribed only in severe alcohol 
dependence and the response to treatment should be monitored regularly and closely 
b
 Doses of chlordiazepoxide in excess of 40mg four times/day should be prescribed only in very severe alcohol 
dependence. Such doses are rarely necessary in women and children and never in older people or in cases of 
liver impairment. 
 
TABLE 3: Suggested titrated fixed-dose chlordiazepoxide protocol for treatment of alcohol 
withdrawal (from [1] p191)   
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